Transaction Details

Footnotes

The total number of shares reported as beneficially owned has been reduced to reflect 13,872 shares of Organon & Co. ("Organon") common stock transferred pursuant to an exemption under Exchange Act Rule 16a-12. | This price is the closing market price of Organon common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. | Includes the addition of 708.122 shares of Organon common stock acquired from dividend equivalents net of withholding tax not previously required to be reported. | Each RSU represents a contingent right to receive one share of Organon common stock. | These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.